Linked e-resources
Details
Table of Contents
Preface. I Fundamental Concepts
Pathophysiology of metastatic bone disease
Bone metastases: epidemiology, clinical picture, SREs and prognosis
Pain in bone metastases: types and mechanisms. II Investigations Of Bone Metastases
Radiological evaluations: radiography, CT, MRI.-Nuclear medicine imaging modalities: bone scintigraphy, PET-CT, SPECT.-Bone turnover markers
New omics approaches for bone metastases. III Therapeutic Management.-Analgesic treatment for bone mets
Radiotherapy: external beam and radio-surgery
Radionuclide therapy
Bisphosphonates
New targeted therapies for bone metastases
Chemotherapy and hormone therapy
HIFU/Radioablation
Neuropathic bone metastases
Spinal cord compression and cauda equina compression
Pathological and impending fracture
Re-irradiation
Bone metastases in elderly patients
Management of metastatic bone disease in the elderly with bisphosphonates and RANKL inhibitors: effectiveness and safety. IV Assesment of Therapeutic Response
Radiological and nuclear medicine imaging modalities.-Clinical assessment measures
Outcome measures in bone metastases clinical trials
Quality of life in patients suffering from metastatic skeletal disease. V Cost of Managing Metastatic Bone Disease
Cost effectiveness of treatment modalities for bone metastases
Index.
Pathophysiology of metastatic bone disease
Bone metastases: epidemiology, clinical picture, SREs and prognosis
Pain in bone metastases: types and mechanisms. II Investigations Of Bone Metastases
Radiological evaluations: radiography, CT, MRI.-Nuclear medicine imaging modalities: bone scintigraphy, PET-CT, SPECT.-Bone turnover markers
New omics approaches for bone metastases. III Therapeutic Management.-Analgesic treatment for bone mets
Radiotherapy: external beam and radio-surgery
Radionuclide therapy
Bisphosphonates
New targeted therapies for bone metastases
Chemotherapy and hormone therapy
HIFU/Radioablation
Neuropathic bone metastases
Spinal cord compression and cauda equina compression
Pathological and impending fracture
Re-irradiation
Bone metastases in elderly patients
Management of metastatic bone disease in the elderly with bisphosphonates and RANKL inhibitors: effectiveness and safety. IV Assesment of Therapeutic Response
Radiological and nuclear medicine imaging modalities.-Clinical assessment measures
Outcome measures in bone metastases clinical trials
Quality of life in patients suffering from metastatic skeletal disease. V Cost of Managing Metastatic Bone Disease
Cost effectiveness of treatment modalities for bone metastases
Index.